US Edition4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA
Summary by News Medical
3 Articles
3 Articles
All
Left
Center
1
Right
News MedicalReposted by 
European Pharmaceutical Manufacturer
European Pharmaceutical Manufacturer4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA
4basebio PLC (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
·United States
Read Full Article
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
